Complete response of recurrent cellular congenital mesoblastic nephroma to chemotherapy

David M. Loeb, D. Ashley Hill, Jeffrey S. Dome

Research output: Contribution to journalArticle

35 Citations (Scopus)

Abstract

Congenital mesoblastic nephroma (CMN) is usually cured by surgery. The sensitivity of this tumor to chemotherapy is unknown. The recent description of a t(12;15)(p13;q25) chromosomal translocation in both cellular CMN and congenital infantile fibrosarcoma suggests that these entities have a common pathogenesis, and that cellular CMN might respond to chemotherapy like congenital infantile fibrosarcoma does. The authors describe three patients with recurrent cellular CMN who showed a complete response to chemotherapy. Based on these patients and a review of the literature, the authors suggest that chemotherapy be considered as a part of the therapy for recurrent or unresectable cellular CMN.

Original languageEnglish (US)
Pages (from-to)478-481
Number of pages4
JournalJournal of Pediatric Hematology/Oncology
Volume24
Issue number6
DOIs
StatePublished - Aug 1 2002
Externally publishedYes

Fingerprint

Mesoblastic Nephroma
Drug Therapy
Fibrosarcoma
Genetic Translocation
Neoplasms

Keywords

  • Cancer recurrence
  • Chemotherapy
  • Congenital infantile fibrosarcoma
  • Mesoblastic nephroma

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Oncology
  • Hematology

Cite this

Complete response of recurrent cellular congenital mesoblastic nephroma to chemotherapy. / Loeb, David M.; Hill, D. Ashley; Dome, Jeffrey S.

In: Journal of Pediatric Hematology/Oncology, Vol. 24, No. 6, 01.08.2002, p. 478-481.

Research output: Contribution to journalArticle

@article{e778dd5cc70e4d0dba03408a93008a77,
title = "Complete response of recurrent cellular congenital mesoblastic nephroma to chemotherapy",
abstract = "Congenital mesoblastic nephroma (CMN) is usually cured by surgery. The sensitivity of this tumor to chemotherapy is unknown. The recent description of a t(12;15)(p13;q25) chromosomal translocation in both cellular CMN and congenital infantile fibrosarcoma suggests that these entities have a common pathogenesis, and that cellular CMN might respond to chemotherapy like congenital infantile fibrosarcoma does. The authors describe three patients with recurrent cellular CMN who showed a complete response to chemotherapy. Based on these patients and a review of the literature, the authors suggest that chemotherapy be considered as a part of the therapy for recurrent or unresectable cellular CMN.",
keywords = "Cancer recurrence, Chemotherapy, Congenital infantile fibrosarcoma, Mesoblastic nephroma",
author = "Loeb, {David M.} and Hill, {D. Ashley} and Dome, {Jeffrey S.}",
year = "2002",
month = "8",
day = "1",
doi = "10.1097/00043426-200208000-00014",
language = "English (US)",
volume = "24",
pages = "478--481",
journal = "Journal of Pediatric Hematology/Oncology",
issn = "1077-4114",
publisher = "Lippincott Williams and Wilkins",
number = "6",

}

TY - JOUR

T1 - Complete response of recurrent cellular congenital mesoblastic nephroma to chemotherapy

AU - Loeb, David M.

AU - Hill, D. Ashley

AU - Dome, Jeffrey S.

PY - 2002/8/1

Y1 - 2002/8/1

N2 - Congenital mesoblastic nephroma (CMN) is usually cured by surgery. The sensitivity of this tumor to chemotherapy is unknown. The recent description of a t(12;15)(p13;q25) chromosomal translocation in both cellular CMN and congenital infantile fibrosarcoma suggests that these entities have a common pathogenesis, and that cellular CMN might respond to chemotherapy like congenital infantile fibrosarcoma does. The authors describe three patients with recurrent cellular CMN who showed a complete response to chemotherapy. Based on these patients and a review of the literature, the authors suggest that chemotherapy be considered as a part of the therapy for recurrent or unresectable cellular CMN.

AB - Congenital mesoblastic nephroma (CMN) is usually cured by surgery. The sensitivity of this tumor to chemotherapy is unknown. The recent description of a t(12;15)(p13;q25) chromosomal translocation in both cellular CMN and congenital infantile fibrosarcoma suggests that these entities have a common pathogenesis, and that cellular CMN might respond to chemotherapy like congenital infantile fibrosarcoma does. The authors describe three patients with recurrent cellular CMN who showed a complete response to chemotherapy. Based on these patients and a review of the literature, the authors suggest that chemotherapy be considered as a part of the therapy for recurrent or unresectable cellular CMN.

KW - Cancer recurrence

KW - Chemotherapy

KW - Congenital infantile fibrosarcoma

KW - Mesoblastic nephroma

UR - http://www.scopus.com/inward/record.url?scp=0036693895&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036693895&partnerID=8YFLogxK

U2 - 10.1097/00043426-200208000-00014

DO - 10.1097/00043426-200208000-00014

M3 - Article

C2 - 12218597

AN - SCOPUS:0036693895

VL - 24

SP - 478

EP - 481

JO - Journal of Pediatric Hematology/Oncology

JF - Journal of Pediatric Hematology/Oncology

SN - 1077-4114

IS - 6

ER -